PharmaShots Weekly Snapshot (September 23-27, 2019)
Published: Sept 27, 2019 | Tags: Incyte, Reports, Updated, Results, Pemigatinib, P-II, FIGHT-202 Trial, Patients, Previously, Treated, Advanced, Cholangiocarcinoma
2.Pfizer Reports Results of Abrocitinib in P-III JADE MONO-2 Study for Moderate to Severe Atopic Dermatitis
Published: Sept 27, 2019 | Tags: Pfizer, Reports, Results, Abrocitinib, P-III, JADE MONO-2 Study, Moderate, Severe, Atopic Dermatitis
Published: Sept 27, 2019 | Tags: Simcere, Signs, Exclusive, License Agreement, JW Pharmaceutical, Anti-Gout Drug Candidate, URC-102, China
4. Ieso Launches Eight Billion Minds Digital Initiative Addressing Unmet Mental Health Needs
Published: Sept 26, 2019 | Tags: Ieso, Launches, Eight Billion Minds, Digital Initiative, Addressing, Unmet, Mental Health Needs
5.Medtronic Reports Results of Resolute Onyx DES in Onyx ONE Global Study for High-Bleeding Risk Patients with One-Month DAPT
Published: Sept 26, 2019 | Tags: Medtronic, Reports, Results, Resolute Onyx DES, Onyx ONE Global Study, High-Bleeding Risk, One-Month DAPT
Published: Sept 26, 2019 | Tags: Janssen, Darzalex, daratumumab, Combination Therapy, Receives, FDA, Approval, Frontline Multiple Myeloma
Published: Sept 26, 2019 | Tags: AbbVie, Mavyret, glecaprevir, pibrentasvir, Receives, FDA, Approval, Expanded Indication, Treatment-Naïve Patients, Chronic Hepatitis C, Compensated Cirrhosis
8. Medtronic to Initiate Clinical Study Evaluating Infuse Bone Graft in TLIF Spine Procedures
Published: Sept 26, 2019 | Tags: Medtronic, Initiate, Clinical Study, Evaluating, Infuse Bone Graft, TLIF Spine Procedures
9. AstraZeneca and Innate Pharma to Advance Monalizumab in a P-III Study for Head and Neck Cancer
Published: Sept 26, 2019 | Tags: AstraZeneca, Innate Pharma, Advance, Monalizumab, P-III, Study, Head and Neck Cancer
10.Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy
Published: Sept 26, 2019 | Tags: Jazz, Reports, Results, JZP-258, P-III, Treat, Cataplexy, EDS, Narcolepsy
Published: Sept 26, 2019 | Tags: Thermo Fisher, Reports, Expansion, Clinical Trials, Capabilities, Collaborates, Frontier, HIV
Published: Sept 25, 2019 | Tags: Abbott, ARCHITECT STAT High Sensitivity Troponin-I Blood Test, Receives, FDA, Clearance, Heart Attacks, Faster, Accurately
Published: Sept 25, 2019 | Tags: Takeda, Reports, Results, Vedolizumab, First, Head-to-Head, Biologic Study, Ulcerative Colitis
Published: Sept 24, 2019 | Tags: Ethicon, Launches, Echelon Circular, Powered Circular Stapler, Colorectal, Gastric, Thoracic, Surgery
15. Achillion's Danicopan (ACH-4471) Receives FDA's Breakthrough Therapy Designation for Paroxysmal Nocturnal Hemoglobinuria
Published: Sept 25, 2019 | Tags: Achillion, Danicopan, ACH-4471, Receives, FDA, Breakthrough Therapy Designation, Paroxysmal Nocturnal Hemoglobinuria
Published: Sept 24, 2019 | Tags: Bavarian Nordic, Jynneos Vaccine, Receives, FDA, Approval, Prevent, Smallpox, Monkeypox Disease, Adults
17.Amgen Reports Results of Blincyto (blinatumomab) in Two P-III Studies for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients
Published: Sept 24, 2019 | Tags: Amgen, Reports, Results, Blincyto, blinatumomab, Relapsed Acute Lymphoblastic Leukemia, Pediatric Patients
Published: Sept 24, 2019 | Tags: Pfizer, Expands, Collaboration, Flatiron Health, Integrate, Real-World Evidence, Oncology
19.Biocon Biologics Acquires Pfizer's Research Facility to Expand its Research and Development Footprint
Published: Sept 24, 2019 | Tags: Biocon Biologics, Acquires, Pfizer, Research Facility, Expand, R&D Footprints
20.Aldeyra's ADX-2191 Receives FDA's Fast Track Designation to Prevent Proliferative Vitreoretinopathy
Published: Sept 03, 2019 | Tags: Aldeyra, ADX-2191, Receives, FDA, Fast Track Designation, Prevent, Proliferative Vitreoretinopathy
21.BMS' Opdivo (nivolumab) Receives CHMP Recommendation for Approval of its Four-Week Dosing Schedule
Published: Sept 24, 2019 | Tags: BMS, Opdivo, nivolumab, Receives, CHMP, Recommendation, Approval, Four-Week Dosing Schedule
22. Takeda Collaborates with Evotec to Discover Clinical Candidates for Multiple Therapeutic Areas
Published: Sept 24, 2019 | Tags: Takeda, Collaborates, Evotec, Discover, Clinical Candidates, Multiple Therapeutic Areas
Published: Sept 24, 2019 | Tags: Bayer, Collaborates, Womens Hospital, Massachusetts General Hospital, Launch, Joint, Chronic Lung Diseases
Published: Sept 23, 2019 | Tags: Sandoz, Voluntary, Recalls, Ranitidine Hydrochloride, N-Nitrosodimethylamine, US
25. Bayer's Vitrakvi (larotrectinib) Receives EMA's Approval as the First Tumor Agonist in Europe
Published: Sept 23, 2019 | Tags: Bayer, Vitrakvi, larotrectinib, Receives, EMA, Approval, First Tumor Agonist, Europe
26. MSD Collaborates with I-Mab to Evaluate Keytruda + TJC4 for Multiple Cancer Indications
Published: Sept 23, 2019 | Tags: MSD, I-Mab, Enters, Clinical Collaboration, Evaluate, Keytruda, TJC4, Cancer
Published: Sept 23, 2019 | Tags: Mallinckrodt, Reports, Results, StrataGraft Regenerative Tissue, P-III, STRATA2016, Study, Deep Partial-thickness Thermal Burns
Published: Sept 23, 2019 | Tags: Celltrion, CT-P13, biosimilar, infliximab, Receives, CHMP Positive Opinion, SC Formulation, Rheumatoid Arthritis
Published: Sept 23, 2019 | Tags: Biogen, Plegridy, peginterferon beta-1a, Avonex, interferon beta-1a, Receive, CHMP, Positive Opinion, Pregnancy, Breastfeeding
30.Clovis Oncology Signs a License Agreement with 3B Pharmaceuticals for FAP-Targeted Radiopharmaceutical Program
Published: Sept 23, 2019 | Tags: Clovis Oncology, Signs, License Agreement, 3B Pharmaceuticals, FAP-Targeted Radiopharmaceutical Program
Published: Sept 23, 2019 | Tags: Novo Nordisk, Rybelsus, semaglutide, Receives, FDA, Approval, GLP-1 Analog, Type 2 Diabetes
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com